Citigroup
BIND

Citigroup’s BIND THERAPEUTICS INC BIND Stock Holding History

Citigroup’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,840
Closed -$6K – 8224
2015
Q4 		$6K Sell
2,840
-2,910
-51% -$11.8K ﹤0.01% 7015
2015
Q3 		$26K Sell
5,750
-498
-8% -$2.44K ﹤0.01% 5864
2015
Q2 		$35K Sell
6,248
-2
-0% -$12 ﹤0.01% 5775
2015
Q1 		$35K Buy
6,250
+387
+7% +$2.38K ﹤0.01% 5761
2014
Q4 		$32K Buy
5,863
+74
+1% +$555 ﹤0.01% 5978
2014
Q3 		$50K Buy
5,789
+390
+7% +$3.85K ﹤0.01% 5312
2014
Q2 		$71K Buy
5,399
+1,832
+51% +$17.9K ﹤0.01% 4917
2014
Q1 		$43K Sell
3,567
-2,046
-36% -$26.7K ﹤0.01% 5595
2013
Q4 		$85K Buy
+5,613
New +$71.4K ﹤0.01% 5366

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citigroup's BIND Position: Q1 2016 in Review

Citigroup sold out of BIND THERAPEUTICS INC (BIND) in Q1 2016, closing a stake of 2,840 shares — an estimated $6K sold.

Citigroup first reported a position in BIND in Q4 2013 and held it in 9 quarters. The position peaked at $85K in Q4 2013. 34 funds tracked by Wall St. Rank hold BIND as of Q1 2016.

  • Citigroup reported no remaining BIND THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 2,840 BIND THERAPEUTICS INC shares in Q1 2016, an estimated $6K.
  • Citigroup first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 9 quarters.
  • Citigroup's BIND THERAPEUTICS INC position peaked at $85K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.